Bone Tissue Composition in Postmenopausal Women Varies With Glycemic Control From Normal Glucose Tolerance to Type 2 Diabetes Mellitus

© 2020 American Society for Bone and Mineral Research (ASBMR)..

The risk of fragility fracture increases for people with type 2 diabetes mellitus (T2DM), even after controlling for bone mineral density, body mass index, visual impairment, and falls. We hypothesize that progressive glycemic derangement alters microscale bone tissue composition. We used Fourier-transform infrared (FTIR) imaging to analyze the composition of iliac crest biopsies from cohorts of postmenopausal women characterized by oral glucose tolerance testing: normal glucose tolerance (NGT; n = 35, age = 65 ± 7 years, HbA1c = 5.8 ± 0.3%), impaired glucose tolerance (IGT; n = 26, age = 64 ± 5 years, HbA1c = 6.0 ± 0.4%), and overt T2DM on insulin (n = 25, age = 64 ± 6 years, HbA1c = 9.13 ± 0.6). The distributions of cortical bone mineral content had greater mean values (+7%) and were narrower (-10%) in T2DM versus NGT groups (p < 0.05). The distributions of acid phosphate, an indicator of new mineral, were narrower in cortical T2DM versus NGT and IGT groups (-14% and -14%, respectively) and in trabecular NGT and IGT versus T2DM groups (-11% and -10%, respectively) (all p < 0.05). The distributions of crystallinity were wider in cortical NGT versus T2DM groups (+16%) and in trabecular NGT versus T2DM groups (+14%) (all p < 0.05). Additionally, bone turnover was lower in T2DM versus NGT groups (P1NP: -25%, CTx: -30%, ucOC: -24%). Serum pentosidine was similar across groups. The FTIR compositional and biochemical marker values of the IGT group typically fell between the NGT and T2DM group values, although the differences were not always statistically significant. In summary, worsening glycemic control was associated with greater mineral content and narrower distributions of acid phosphate, an indicator of new mineral, which together are consistent with observations of lower turnover; however, wider distributions of mineral crystallinity were also observed. A more mineralized, less heterogeneous tissue may affect tissue-level mechanical properties and in turn degrade macroscale skeletal integrity. In conclusion, these data are the first evidence of progressive alteration of bone tissue composition with worsening glycemic control in humans. © 2020 American Society for Bone and Mineral Research (ASBMR).

Errataetall:

CommentIn: Nat Rev Endocrinol. 2020 Dec;16(12):678-679. - PMID 33046852

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:36

Enthalten in:

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research - 36(2021), 2 vom: 18. Feb., Seite 334-346

Sprache:

Englisch

Beteiligte Personen:

Hunt, Heather B [VerfasserIn]
Miller, Nicholas A [VerfasserIn]
Hemmerling, Kimberly J [VerfasserIn]
Koga, Maho [VerfasserIn]
Lopez, Kelsie A [VerfasserIn]
Taylor, Erik A [VerfasserIn]
Sellmeyer, Deborah E [VerfasserIn]
Moseley, Kendall F [VerfasserIn]
Donnelly, Eve [VerfasserIn]

Links:

Volltext

Themen:

BIOCHEMICAL MARKERS OF BONE TURNOVER
Blood Glucose
FRACTURE RISK
Glucose
IY9XDZ35W2
Insulin
Journal Article
POSTMENOPAUSAL WOMEN
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
TYPE 2 DIABETES MELLITUS

Anmerkungen:

Date Completed 09.08.2021

Date Revised 21.09.2022

published: Print-Electronic

CommentIn: Nat Rev Endocrinol. 2020 Dec;16(12):678-679. - PMID 33046852

Citation Status MEDLINE

doi:

10.1002/jbmr.4186

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM315417250